Cargando…

Effective presence of antibodies against common human coronaviruses in immunoglobulin medicinal products

BACKGROUND: Immunoglobulin products (for intravenous, intramuscular and subcutaneous administration) prepared from geographically diverse plasma pools were tested for activity against common human coronaviruses (HCoVs). Products from plasma obtained from Germany, Czech Republic, Slovak Republic, USA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Díez, José María, Romero, Carolina, Gajardo, Rodrigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679496/ https://www.ncbi.nlm.nih.gov/pubmed/34929360 http://dx.doi.org/10.1016/j.ijid.2021.12.329

Ejemplares similares

Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens
por: Díez, José-María, et al.
Publicado: (2020)

Surveillance of anti-SARS-CoV-2 antibodies in plasma pools and in immunoglobulin medicinal products manufactured since 2020 has shown high neutralizing activity against SARS-CoV-2 and current variants
por: Romero, Carolina, et al.
Publicado: (2023)

Medicinal Immunoglobulin G Products (2020) Show High Infectivity Neutralizing Activity Against Seasonal Influenza Virus Strains Selected for Future Vaccines (2020–2022)
por: Díez, José María, et al.
Publicado: (2022)

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products
por: Romero, Carolina, et al.
Publicado: (2021)

Anti-SARS-CoV-2 antibodies in healthy donor plasma pools and IVIG products—an update
por: Romero, Carolina, et al.
Publicado: (2022)

Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Hyperimmune Immunoglobulin Demonstrates Potent Neutralization and Antibody-Dependent Cellular Cytotoxicity and Phagocytosis Through N and S Proteins
por: Díez, José María, et al.
Publicado: (2021)

Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
por: Díez, José María, et al.
Publicado: (2020)

Presence of Antibodies against Genogroup VI Norovirus in Humans
por: Mesquita, João Rodrigo, et al.
Publicado: (2013)

Commercial Immunoglobulin Products Contain Neutralizing Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein
por: Upasani, Vinit, et al.
Publicado: (2023)

Production and purification of polyclonal antibody against F(ab')2 fragment of human immunoglobulin G
por: Nasiri, Hadi, et al.
Publicado: (2017)

Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products
por: Lee, Soyoung, et al.
Publicado: (2016)

Indigenous production, characterization and evaluation of polyclonal antibody against Camelus dromedarius immunoglobulin
por: Yektaseresht, Azadeh, et al.
Publicado: (2022)

Characterization of antibodies in human immunoglobulin products from different regions worldwide
por: Serra, Alexandra, et al.
Publicado: (2021)

Production of monoclonal antibodies against serum immunoglobulins of black rockfish (Sebastes schlegeli Higendorf)
por: Shin, Geewook, et al.
Publicado: (2006)

Novel Antibody–Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma
por: Zeneyedpour, Lona, et al.
Publicado: (2022)

Human mesenchymal stem cells maintain their phenotype, multipotentiality, and genetic stability when cultured using a defined xeno-free human plasma fraction
por: Blázquez-Prunera, Arantxa, et al.
Publicado: (2017)

Commercial immunoglobulin products contain cross-reactive but not neutralizing antibodies against SARS-CoV-2
por: Ahn, Terrie S., et al.
Publicado: (2021)

Cattle engineered to produce human antibodies against coronavirus
por: Bray, Natasha
Publicado: (2016)

Detection of serum immunoglobulin M and immunoglobulin G antibodies in 2019 novel coronavirus infected patients from different stages
por: Gao, Hui-Xia, et al.
Publicado: (2020)

Presence of Nitrosamine Impurities in Medicinal Products
por: Sedlo, Ilijana, et al.
Publicado: (2021)

Coronavirus fulminant myocarditis treated with glucocorticoid and human immunoglobulin
por: Hu, Hongde, et al.
Publicado: (2020)

Coronavirus disease 2019, vaccination against coronavirus and immunoglobulin A-mediated diseases: systematic literature review
por: Bronz, Gabriel, et al.
Publicado: (2022)

Culture of human mesenchymal stem cells using a candidate pharmaceutical grade xeno-free cell culture supplement derived from industrial human plasma pools
por: Díez, José M, et al.
Publicado: (2015)

ANTIBODY AND IMMUNOGLOBULIN PRODUCTION AT THE CELLULAR LEVEL IN BURSECTOMIZED-IRRADIATED CHICKENS
por: Alm, Gunnar V., et al.
Publicado: (1969)

Detection of SARS-CoV-2 Antibodies in Immunoglobulin Products
por: Cousins, Kimberley, et al.
Publicado: (2023)

Production of specific antibodies against SARS-coronavirus nucleocapsid protein without cross reactivity with human coronaviruses 229E and OC43
por: Lee, Hyun-Kyoung, et al.
Publicado: (2010)

Monoclonal antibodies against bovine immunoglobulins and their use in isotype-specific ELISAs for rotavirus antibody
por: Van Zaane, Dick, et al.
Publicado: (1984)

Detection and Profiling of Human Coronavirus Immunoglobulins in Critically Ill Coronavirus Disease 2019 Patients
por: Fraser, Douglas D., et al.
Publicado: (2021)

Corrigendum to: Coronavirus fulminant myocarditis saved with glucocorticoid and human immunoglobulin
Publicado: (2020)

Role of Immunoglobulin M and A Antibodies in the Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2
por: Klingler, Jéromine, et al.
Publicado: (2020)

Production of a monoclonal antibody against chicken immunoglobulin G: A valuable molecule with research and diagnostic applications
por: Seyfi Abad Shapouri, Masoud Reza, et al.
Publicado: (2018)

Distinct antibody repertoires against endemic human coronaviruses in children and adults
por: Khan, Taushif, et al.
Publicado: (2021)

Diagnostic indexes of a rapid immunoglobulin G/immunoglobulin M combined antibody test for severe acute respiratory syndrome coronavirus 2
por: Liu, Ying, et al.
Publicado: (2021)

Positive outcome in a patient with coronavirus disease 2019 and common variable immunodeficiency after intravenous immunoglobulin
por: Aljaberi, Rana, et al.
Publicado: (2020)

Production and Evaluation of Chicken Egg Yolk Immunoglobulin (IgY) against Human and Simian Rotaviruses
por: Bentes, Gentil Arthur, et al.
Publicado: (2022)

Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products
por: Manian, Deepti Vellaichamy, et al.
Publicado: (2021)

Protective anti‐prion antibodies in human immunoglobulin repertoires
por: Senatore, Assunta, et al.
Publicado: (2020)

A monoclonal antibody against the nucleus reveals the presence of a common protein in the nuclear envelope, the perichromosomal region, and cytoplasmic vesicles
Publicado: (1987)

Detection of Antibodies Against Human Leukocyte Antigen Class II in the Sera of Patients Receiving Intravenous Immunoglobulin
por: Takamatsu, Hiroyuki, et al.
Publicado: (2021)

Antibody against nucleocapsid protein predicts susceptibility to human coronavirus infection
por: Gao, Xin, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_d50la6n0mqdr8p753otdtsucut